264 related articles for article (PubMed ID: 20000778)
1. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
[TBL] [Abstract][Full Text] [Related]
2. Interactions between nitric oxide and indoleamine 2,3-dioxygenase.
Samelson-Jones BJ; Yeh SR
Biochemistry; 2006 Jul; 45(28):8527-38. PubMed ID: 16834326
[TBL] [Abstract][Full Text] [Related]
3. A specific interaction of L-tryptophan with CO of CO-bound indoleamine 2,3-dioxygenase identified by resonance Raman spectroscopy.
Yanagisawa S; Sugimoto H; Shiro Y; Ogura T
Biochemistry; 2010 Nov; 49(47):10081-8. PubMed ID: 21028817
[TBL] [Abstract][Full Text] [Related]
4. Human indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide.
Freewan M; Rees MD; Plaza TS; Glaros E; Lim YJ; Wang XS; Yeung AW; Witting PK; Terentis AC; Thomas SR
J Biol Chem; 2013 Jan; 288(3):1548-67. PubMed ID: 23209301
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of indoleamine 2,3 dioxygenase activity by H2O2.
Poljak A; Grant R; Austin CJ; Jamie JF; Willows RD; Takikawa O; Littlejohn TK; Truscott RJ; Walker MJ; Sachdev P; Smythe GA
Arch Biochem Biophys; 2006 Jun; 450(1):9-19. PubMed ID: 16624246
[TBL] [Abstract][Full Text] [Related]
6. Redox and spectroscopic properties of human indoleamine 2,3-dioxygenase and a His303Ala variant: implications for catalysis.
Papadopoulou ND; Mewies M; McLean KJ; Seward HE; Svistunenko DA; Munro AW; Raven EL
Biochemistry; 2005 Nov; 44(43):14318-28. PubMed ID: 16245948
[TBL] [Abstract][Full Text] [Related]
7. Identification of potent virtual leads to design novel indoleamine 2,3-dioxygenase inhibitors: pharmacophore modeling and molecular docking studies.
John S; Thangapandian S; Sakkiah S; Lee KW
Eur J Med Chem; 2010 Sep; 45(9):4004-12. PubMed ID: 20580138
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast.
Vottero E; Balgi A; Woods K; Tugendreich S; Melese T; Andersen RJ; Mauk AG; Roberge M
Biotechnol J; 2006 Mar; 1(3):282-8. PubMed ID: 16897708
[TBL] [Abstract][Full Text] [Related]
9. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
Yue EW; Douty B; Wayland B; Bower M; Liu X; Leffet L; Wang Q; Bowman KJ; Hansbury MJ; Liu C; Wei M; Li Y; Wynn R; Burn TC; Koblish HK; Fridman JS; Metcalf B; Scherle PA; Combs AP
J Med Chem; 2009 Dec; 52(23):7364-7. PubMed ID: 19507862
[TBL] [Abstract][Full Text] [Related]
11. In vitro modulation of cytochrome P450 reductase supported indoleamine 2,3-dioxygenase activity by allosteric effectors cytochrome b(5) and methylene blue.
Pearson JT; Siu S; Meininger DP; Wienkers LC; Rock DA
Biochemistry; 2010 Mar; 49(12):2647-56. PubMed ID: 20178337
[TBL] [Abstract][Full Text] [Related]
12. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2,3-dioxygenase in human monocytic cells.
López AS; Alegre E; Díaz A; Mugueta C; González A
Immunol Lett; 2006 Aug; 106(2):163-71. PubMed ID: 16797727
[TBL] [Abstract][Full Text] [Related]
13. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds.
Mishra B; Priyadarsini KI; Mohan H; Mugesh G
Bioorg Med Chem Lett; 2006 Oct; 16(20):5334-8. PubMed ID: 16919452
[TBL] [Abstract][Full Text] [Related]
14. Human tryptophan dioxygenase: a comparison to indoleamine 2,3-dioxygenase.
Batabyal D; Yeh SR
J Am Chem Soc; 2007 Dec; 129(50):15690-701. PubMed ID: 18027945
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.
Huang Q; Zheng M; Yang S; Kuang C; Yu C; Yang Q
Eur J Med Chem; 2011 Nov; 46(11):5680-7. PubMed ID: 21925773
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the nitrosyl adduct of substrate-bound mouse cysteine dioxygenase by electron paramagnetic resonance: electronic structure of the active site and mechanistic implications.
Pierce BS; Gardner JD; Bailey LJ; Brunold TC; Fox BG
Biochemistry; 2007 Jul; 46(29):8569-78. PubMed ID: 17602574
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin induces the expression of indoleamine 2,3-dioxygenase in dendritic cells through the activation of PI3K, PKC, and NF-kappaB and the generation of reactive oxygen species.
Ogasawara N; Oguro T; Sakabe T; Matsushima M; Takikawa O; Isobe K; Nagase F
J Cell Biochem; 2009 Oct; 108(3):716-25. PubMed ID: 19693771
[TBL] [Abstract][Full Text] [Related]
18. Post-translational regulation of human indoleamine 2,3-dioxygenase activity by nitric oxide.
Thomas SR; Terentis AC; Cai H; Takikawa O; Levina A; Lay PA; Freewan M; Stocker R
J Biol Chem; 2007 Aug; 282(33):23778-87. PubMed ID: 17535808
[TBL] [Abstract][Full Text] [Related]
19. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
Smith JR; Evans KJ; Wright A; Willows RD; Jamie JF; Griffith R
Bioorg Med Chem; 2012 Feb; 20(3):1354-63. PubMed ID: 22112538
[TBL] [Abstract][Full Text] [Related]
20. Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors.
Lancellotti S; Novarese L; De Cristofaro R
Curr Med Chem; 2011; 18(15):2205-14. PubMed ID: 21517759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
